Intravenous fluids are fluids that are given to a patient intravenously (via the veins) or directly through the circulatory system. To prevent patients from damage, these fluids must be sterile, and there are various options. Many companies manufacture pre-packaged intravenous fluids and other things that can be added with sterile water to form an intravenous solution.
Two types of intravenous fluids are available. Crystalloids contain a solution of water-soluble molecules, such as saline solutions. Colloids are formed composed of particles that aren't soluble in water and produce a high osmotic pressure, which draws fluid into blood vessels.
In addition to delivering fluids, intravenous fluids can also be used to administer drugs. A doctor can dissolve a little amount of medication in a bag of intravenous fluids and infuse the medicated fluid directly into the bloodstream over a long period of time using an infusion pump. Fluids are also commonly used to help patients recover from surgery; patients who receive fluids after surgery recover faster than those who do not.
A variety of solutions are used for IV fluids. The one chosen is based on the circumstances. Several more compounds can be added to the IV solution as a simple mechanism of delivery. Antibiotics, pain painkillers, and other medications can be added to the IV so that the patient receives the medication at a steady rate.
Dextrose (also known as D-glucose, Corn Sugar, Starch Sugar, Blood Sugar, and Grape Sugar) is the most abundant sugar in nature, and it can be found in its free state (mono saccharine form) or chemically bonded with other sugars. It can be found in large concentrations in honey, fruits, and berries in the Free State.
• Electrolyte metabolism and treatment of waste water, especially in extreme cases.
• Treatment for acid-base imbalances.
• Dextrose solution is used to minimise salt extraction during the postoperative phase.
• To improve urine flow, a dextrose solution with a concentration of 10-15% is used as a diuretic.
• When a substantial amount of salt has been lost through vomiting, gastric or intestine duodenal aspiration, or an alimentary fistula, saline solution is utilized.
Intravenous (IV) fluids have a variety of uses in medicine, including restoring critical nutrients or compounds that the body cannot create on its own. IV fluids are also commonly used in medical situations, such as accidents or illnesses, when someone has lost a significant amount of fluid from their body and need fast rehydration and electrolyte and vitamin replacement. If IV fluids are required to treat a sickness or disease, doctors will regularly monitor the patient's status to ensure that it does not worsen and that his or her health improves swiftly and effectively.
In 2015, the global intravenous (IV) solutions market was worth USD 6.9 billion, and it is expected to increase at a CAGR of 7.8% over the next five years. The rise of this market can be ascribed to the rapidly rising geriatric population as well as the high frequency of malnutrition among the elderly and children.
The market for intravenous (IV) solution is estimated to reach USD 11,511.2 million by 2022, with a compound annual growth rate (CAGR) of 7.69 percent from 2016 to 2022. The rising frequency of chronic diseases, as well as the rising acceptability of vitamin C intravenous treatment therapy to treat colorectal cancer, are driving market expansion.
This is due to variables such as the growing acceptability of intravenous vitamin C for colorectal cancer and the rising prevalence of chronic disorders. Europe is the second largest market, with an annual growth rate of 8.12% from 2016 to 2022. The Asia-Pacific area is the fastest-growing market for IV Solutions, with a CAGR of 8.34 percent predicted from 2016 to 2022.
Key Players:
· Abaris Healthcare Pvt. Ltd.
· Ahlcon Parenterals (India) Ltd.
· Axa Parenterals Ltd.
· Infutec Healthcare Ltd.
· Kokad Pharmaceutical Laboratories Ltd.
· Parenteral Surgicals Ltd.
